LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pulmonary Neuroendocrine Cells Function as Airway Sensors to Control Immune Response in the Lung

By LabMedica International staff writers
Posted on 24 Jan 2016
Image: Pulmonary neuroendocrine cells (red) are rare cells found in clusters along the mammalian airway, where they act as sensors, sending information to the central nervous system. These clusters are found interspersed among other airway epithelial cells (green) (Photo courtesy of Dr. Leah Nantie, University of Wisconsin).
Image: Pulmonary neuroendocrine cells (red) are rare cells found in clusters along the mammalian airway, where they act as sensors, sending information to the central nervous system. These clusters are found interspersed among other airway epithelial cells (green) (Photo courtesy of Dr. Leah Nantie, University of Wisconsin).
Researchers have found that pulmonary neuroendocrine cells (PNECs) sense environmental stimuli and transmit this information to the nervous system, which orchestrates an immune response in the lung.

PNECs, which comprise only about 1% of the cells in the airway epithelium, occur in the lung as solitary cells or as clusters called neuroepithelial bodies (NEB). They are also located in the nasal respiratory epithelium, laryngeal mucosa, and throughout the entire respiratory tract from the trachea to the terminal airways. PNECs have been implicated in a wide range of human lung diseases, including asthma, pulmonary hypertension, cystic fibrosis, and sudden infant death syndrome, among others. Until now, their normal function in living animals was unknown.

As part of a larger study on congenital respiratory disorders, investigators at the University of Wisconsin (Madison, USA) found that Roundabout receptor (Robo) genes were expressed in PNECs. In a mutant model, Robo inactivation in the mouse lung resulted in an inability of PNECs to cluster into sensory organoids and triggered increased neuropeptide production upon exposure to air. Excess neuropeptides led to an increase in immune infiltrates, which in turn remodeled the matrix and irreversibly simplified the alveoli.

The investigators stated in the January 7, 2016, online edition of the journal Science that they had demonstrated in vivo that PNECs acted as precise airway sensors that elicited immune responses via neuropeptides. These findings suggested that the PNEC and neuropeptide abnormalities documented in a wide array of pulmonary diseases may profoundly impact symptoms and progression.

"These cells make up less than 1% of the cells in the airway epithelium, the layer of cells that lines the respiratory tract," said senior author Dr. Xin Sun, professor of medical genetics at the University of Wisconsin. "In the mutant, they do not cluster. They stay as solitary cells, and as single cells they are much more sensitive to the environment. Our conclusion is that they are capable of receiving, interpreting, and responding to environmental stimuli such as allergens or chemicals mixed with the air we breathe."

Related Links:

University of Wisconsin


New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
ESR Analyzer
TEST1 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more